Enhancing tabletability of high-dose tablets by tailoring properties of spray-dried insulin particles
- PMID: 36565770
- DOI: 10.1016/j.ijpharm.2022.122526
Enhancing tabletability of high-dose tablets by tailoring properties of spray-dried insulin particles
Abstract
The oral delivery of proteins and peptides provides an attractive dosing option due to its high patient compliance. However, as oral formulations of such macromolecules require the addition of typically poorly compactable permeation enhancers, the compression behaviour in tableting processes can become challenging. In this study, we show that poor compression behaviour can be overcome by tailoring the properties of peptide or protein particles, especially in high-dose tablet formulations. Spray-dried particles with varying particle size and morphology were produced and characterized. The particles were then evaluated for tabletability in well- and poorly tabletable formulations. Tabletability was found to be enhanced most with small and non-hollow spray-dried insulin particles in both formulations. The enhancement was more pronounced in the poorly tabletable formulation than in the well-tabletable one. Thus, the API particle properties play a key role, when evaluating manufacturability of poorly tabletable formulations.
Keywords: High-dose formulations; Insulin; MCC (CAS: 9004-34-6); Magnesium stearate (CAS: 557-04-0); Maltitol (CAS: 585-88-6); Oral drug delivery; Oral peptide formulations; Oral protein formulations; Sorbitol (CAS: 50-70-4); Spray-dried particles; Starch (CAS: 9005-25-8); Tablet manufacturing; Tabletability.
Copyright © 2022 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
